SEC Form 4 · accession 0001765581-19-000008
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Patrick Miller
Officer — EVP, US Commercial
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Feb 25, 2019 | F | 528 | $126.25 | D | 24,517 | D | |
| Ordinary Shares | Feb 26, 2019 | F | 414 | $127.76 | D | 24,103 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2Includes 73 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.